Nasivin Vicks Baby (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it causes blood‑vessel constriction, reducing swelling and fluid buildup in the nasal passages, which opens the airway and improves breathing.

The exact dose and frequency are determined by a prescriber or according to the product label. Typically, a few sprays per nostril are used, but the caregiver should follow the specific instructions provided by a healthcare professional.

Safety data for oxymetazoline in pregnancy and lactation are limited. Use only if clearly needed and after consulting a qualified health professional. The prescriber will weigh potential benefits against any possible risks.

Enquiries can be submitted on the product page at gnhindia.com by entering the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Oxymetazoline provides rapid, localized vasoconstriction and typically lasts longer than older agents such as phenylephrine. It is formulated for pediatric use, whereas some alternatives may lack specific dosing guidance for infants, making Nasivin Vicks Baby a preferred choice for short‑term relief in this age group.

Store the nasal spray at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

The product is a nasal spray intended for intranasal use. The caregiver gently inserts the tip into each nostril and delivers the prescribed number of sprays, usually while the child is seated or lying with the head slightly tilted back.

Serious risks, though rare, include significant increases in blood pressure, rapid heart rate, severe allergic reactions, and rebound nasal congestion if used for more than three consecutive days. Any signs of these conditions should prompt immediate medical evaluation.

Children younger than 6 months, individuals with known hypersensitivity to oxymetazoline or any formulation component, and patients with uncontrolled hypertension, severe cardiovascular disease, or those taking MAO inhibitors should avoid using this product.